Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
IntellIA is an artificial intelligence company based in Punta del Este, Uruguay. Its official positioning is to turn data into intelligent decisions, providing applied AI solutions for healthcare, retail, enterprises, and government organizations. Its core products include VivIAM, an intelligent healthcare software platform; a computer-vision-based retail shelf audit solution; and custom AI agents and multi-agent platforms for enterprises.
In healthcare, VivIAM offers diagnostic assistance, automated medical report generation, intelligent electronic medical records, and real-time clinical support. According to the website, it has undergone more than 3 years of R&D and has achieved 93-98% diagnostic accuracy across multiple specialty scenarios, saves 50% of time, and has a satisfaction rating of 4.5/5. In retail, the company uses computer vision to analyze shelves, detect products, measure Share of Space, and verify execution against planograms. Enterprise AI agents are another key focus: these agents can understand natural language, voice, images, and documents, perform system actions at a configurable level of autonomy, and hand off to humans when needed.
The website does not disclose public pricing, plans, free quotas, or self-service trials. Sales appear to be driven mainly through demo bookings and project consultations, which makes it more suitable for customized deployments. In terms of integration, IntellIA says its agents can run across channels such as WhatsApp, Web, Telegram, Slack, and Email, and can connect to existing business systems; however, it does not publish API documentation, SDKs, or a list of standard connectors. On privacy, VivIAM is labeled as HIPAA and GDPR compliant, while the agent platform emphasizes role-based permissions, rule governance, and traceable operations. Details such as data storage, encryption, and training-data usage policies are not disclosed.
The strengths are clear industry implementation scenarios: the healthcare and retail solutions come with concrete metrics, and the enterprise agents go beyond simple Q&A by emphasizing action execution, multi-channel support, and multi-agent collaboration. The limitation is a lack of transparency: underlying models, pricing, implementation timelines, clinical validation details, and API capabilities are not sufficiently public. Although the reported medical accuracy is high, there is no explanation of sample size, disease scope, or third-party evaluation, so further due diligence is necessary before procurement.
IntellIA is better suited to healthcare institutions, retail companies, government agencies, and mid-to-large enterprises in Latin America or Spanish-speaking markets that need customized AI implementation. For Chinese users, the website does not state whether it is accessible from mainland China, supports RMB payment, offers a Chinese interface, or provides Chinese-language customer support, so china_access can only be considered unknown. If deploying in China, it is advisable to first confirm network connectivity, cross-border data compliance, payment methods, and local alternatives. For enterprise AI agents, users may compare it with Dify, Coze, Microsoft Copilot Studio, and similar platforms; for healthcare and retail vision solutions, evaluation should be combined with local compliance-focused vendors.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on intellia.online official site.
intellia.online is an Uruguay AI Apps provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach intellia.online directly.